SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-050496
Filing Date
2018-08-08
Accepted
2018-08-08 16:06:41
Documents
60
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14097_110q.htm 10-Q 811104
2 EX-10.1 a18-14097_1ex10d1.htm EX-10.1 36533
3 EX-31.1 a18-14097_1ex31d1.htm EX-31.1 11931
4 EX-31.2 a18-14097_1ex31d2.htm EX-31.2 11947
5 EX-32.1 a18-14097_1ex32d1.htm EX-32.1 7684
  Complete submission text file 0001104659-18-050496.txt   4590542

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cldx-20180630.xml EX-101.INS 1088526
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldx-20180630.xsd EX-101.SCH 31785
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cldx-20180630_cal.xml EX-101.CAL 48610
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cldx-20180630_lab.xml EX-101.LAB 348900
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldx-20180630_pre.xml EX-101.PRE 251131
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldx-20180630_def.xml EX-101.DEF 128124
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 181001375
SIC: 2835 In Vitro & In Vivo Diagnostic Substances